Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
26 hedge funds and large institutions have $2.79M invested in Vaccinex, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
165% more capital invested
Capital invested by funds: $1.05M → $2.79M (+$1.74M)
44% more funds holding
Funds holding: 18 → 26 (+8)
27% less call options, than puts
Call options by funds: $617K | Put options by funds: $845K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$336K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$200K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$185K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$145K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$132K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$84K |
| 2 |
Goldman Sachs
New York
|
-$45.6K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$41.8K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$10K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$3.86K |
VCNX Hedge Fund Activity: Q1 2021 in Review
26 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q1 2021, worth a combined $2.79M — up 165% from $1.05M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VCNX positions and 4 closed out — a net gain of 8 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $336K. The largest seller was Squarepoint, exiting entirely with an estimated $84K sold.
- 26 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q1 2021, up from 18 in Q4 2020.
- Funds reported $2.79M of Vaccinex, Inc. Common Stock stock for Q1 2021, up 165% quarter-over-quarter.
- 12 funds opened new Vaccinex, Inc. Common Stock positions in Q1 2021 and 4 closed out, a net change of +8 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q1 2021 was Susquehanna International Group, an estimated $336K added.
- The largest Vaccinex, Inc. Common Stock seller in Q1 2021 was Squarepoint, an estimated $84K sold.
Based on aggregated 13F filings for Q1 2021.